Literature DB >> 24762496

The investigation of changes in proteins expression (Apolipoprotein A1 and albumin) in malignant astrocytoma brain tumor.

Mehrdad Hashemi1, Mehdi Pooladi, Solmaz Khaghani Razi Abad.   

Abstract

OBJECTIVE: Angiogenesis performs a critical role in the development of cancer. Angiogenesis research is a cutting-edge field in cancer research. Proteomics is a powerful tool in identifying multiple proteins that are altered following a neuropharacological intervention in a disease of the central nervous system. Diagnostic oncoproteomics is the application of proteomic techniques for the diagnosis of malignancies.
MATERIALS AND METHODS: We extracted proteins of tumor and normal brain tissues and then evaluated the protein purity by Bradford test and spectrophotometery method. In this study, we separated proteins by two-dimensional (2D) gel electrophoresis method and the spots were then analyzed and compared using statistical data and specific software, after providing three-dimensional images of spots alteration. Spots were identified by pH isoelectric, molecular weights, and data banks.
RESULTS: Simple statistical test were used to establish a putative hierarchy in which the change in protein level were ranked according a cutoff point with P < 0.05. Apolipoprotein A1 (apo A1) protein and albumin were consistently upregulated in astrocytoma brain tumors.
CONCLUSION: The vascular microenvironment of glioma play a major role in determining the pathophysiological character is tics of the tumor. apo A1 and albumin are very significant due to their functional consequences in glioma tumor growth, migration and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762496     DOI: 10.4103/0973-1482.131413

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  5 in total

1.  Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.

Authors:  Chong Han; Yang He; Lifen Chen; Jie Wang; Song Jiao; Xiangping Xia; Gang Li; Shengtao Yao
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

Review 2.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

3.  Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors.

Authors:  Saicharan Ghantasala; Medha Gayathri J Pai; Deeptarup Biswas; Nikita Gahoi; Shuvolina Mukherjee; Manubhai Kp; Mehar Un Nissa; Alisha Srivastava; Sridhar Epari; Prakash Shetty; Aliasgar Moiyadi; Sanjeeva Srivastava
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

4.  CT perfusion with acetazolamide challenge in C6 gliomas and angiogenesis.

Authors:  Na Lu; Yue Di; Xiao-Yuan Feng; Jin-Wei Qiang; Jia-wen Zhang; Yong-gang Wang; Ying Liu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model.

Authors:  Linpei Zhang; Yuqiu Li; Wenshu Meng; Yanying Ni; Youhe Gao
Journal:  Cancer Med       Date:  2019-05-15       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.